Neurodegenerative disorders comprise a group of conditions, including Parkinson’s and Alzheimer’s disease, in which neurons in specific brain regions deteriorate. Different neurodegenerative diseases exhibit distinct patterns of brain damage. Despite this, they often present with similar features in the beginning, and a ‘typical’ clinical picture can take years to develop. Establishing a diagnosis early in the disease course can be challenging, even for experts. Brain imaging with 18F-FDG PET may offer a solution, as 18F-FDG PET can be used to identify areas with disrupted glucose metabolism caused by the underlying disease process. In this thesis, several distinguishable disease-related patterns were identified in 18F-FDG PET brain scans u...
The present work explores brain functional changes in drug-naïve Parkinson's disease (PD) patients b...
peer reviewedBACKGROUND: [18F]FDG-PET hypometabolism patterns are indicative of different neurodegen...
F FDG-PET) has gained a leading role in the diagnostic assessment of patients with cognitive complai...
Neurodegenerative disorders comprise a group of conditions, including Parkinson’s and Alzheimer’s di...
Neurodegenerative disorders comprise a group of conditions, including Parkinson’s and Alzheimer’s di...
Neurodegenerative disorders comprise a group of conditions, including Parkinson’s and Alzheimer’s di...
The differential diagnosis of neurodegenerative brain diseases on clinical grounds is difficult, esp...
The differential diagnosis of neurodegenerative brain diseases on clinical grounds is difficult, esp...
The differential diagnosis of neurodegenerative brain diseases on clinical grounds is difficult, esp...
The differential diagnosis of neurodegenerative brain diseases on clinical grounds is difficult, esp...
Objective To delineate the cerebral metabolic patterns presented in 18F-FDG PET images in various t...
Background: iRBD is commonly considered to be a prodromal stage of alpha-synucleinopathies such as P...
Background: iRBD is commonly considered to be a prodromal stage of alpha-synucleinopathies such as P...
Network analysis of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is an innovative...
BACKGROUND: [18F]FDG-PET hypometabolism patterns are indicative of different neurodegenerative condi...
The present work explores brain functional changes in drug-naïve Parkinson's disease (PD) patients b...
peer reviewedBACKGROUND: [18F]FDG-PET hypometabolism patterns are indicative of different neurodegen...
F FDG-PET) has gained a leading role in the diagnostic assessment of patients with cognitive complai...
Neurodegenerative disorders comprise a group of conditions, including Parkinson’s and Alzheimer’s di...
Neurodegenerative disorders comprise a group of conditions, including Parkinson’s and Alzheimer’s di...
Neurodegenerative disorders comprise a group of conditions, including Parkinson’s and Alzheimer’s di...
The differential diagnosis of neurodegenerative brain diseases on clinical grounds is difficult, esp...
The differential diagnosis of neurodegenerative brain diseases on clinical grounds is difficult, esp...
The differential diagnosis of neurodegenerative brain diseases on clinical grounds is difficult, esp...
The differential diagnosis of neurodegenerative brain diseases on clinical grounds is difficult, esp...
Objective To delineate the cerebral metabolic patterns presented in 18F-FDG PET images in various t...
Background: iRBD is commonly considered to be a prodromal stage of alpha-synucleinopathies such as P...
Background: iRBD is commonly considered to be a prodromal stage of alpha-synucleinopathies such as P...
Network analysis of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is an innovative...
BACKGROUND: [18F]FDG-PET hypometabolism patterns are indicative of different neurodegenerative condi...
The present work explores brain functional changes in drug-naïve Parkinson's disease (PD) patients b...
peer reviewedBACKGROUND: [18F]FDG-PET hypometabolism patterns are indicative of different neurodegen...
F FDG-PET) has gained a leading role in the diagnostic assessment of patients with cognitive complai...